Mindfulness-Based Peak Performance, Endurance Performance Under Pressure, Performance-relevant Mental Attributes
Launched by NATIONAL TAIWAN NORMAL UNIVERSITY · Nov 4, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a program called Mindfulness-based Peak Performance (MBPP) to see how it affects athletes' endurance and mental performance under pressure. The goal is to find out if practicing mindfulness can help improve not just physical performance during sports, but also important mental skills like focus and stress management. Researchers believe that those who participate in the MBPP program will perform better than those using a different technique called self-talk.
To join the study, participants need to be between 18 and 30 years old, have good vision, and be able to read and speak Chinese. They should also be physically fit and have some experience in sports like middle-long running, marathons, or triathlons, but not have any prior training in mindfulness practices. Participants can expect to take part in various assessments and training sessions, and they will be randomly assigned to one of three groups to compare results. This study is currently recruiting, and it offers a unique opportunity to explore the benefits of mindfulness in sports performance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged between 18 and 30 years
- • Normal or corrected-to-normal 20/20 vision
- • No red-green color blindness
- • Able to speak and read Chinese
- • Physical Activity Readiness Questionnaire (PAR-Q) score = 0
- • With one of the designated sport proficiencies (i.e., middle-long running, marathon, triathlon)
- • No previous major experience in mindfulness-related training (e.g., meditation or Tai Chi)
- • Provide informed consent
- Exclusion Criteria:
- • Diagnosed or self-reported cognitive problems
- • The diagnosed or self-reported physical disease (e.g., untreated hypertension and chronic heart disease, stroke, brain tumor, musculoskeletal disorders, other exercise contradictions)
- • Diagnosed or self-reported major psychiatric illness (e.g., major depression, schizophrenia)
- • History of alcohol or drug abuse
- • Unwillingness to be randomized to one of the three groups
- • Currently participating in another study trial
About National Taiwan Normal University
National Taiwan Normal University (NTNU) is a prestigious institution dedicated to advancing education and research across various disciplines, including health sciences. As a clinical trial sponsor, NTNU leverages its academic expertise and innovative methodologies to investigate and develop novel therapeutic interventions. The university fosters collaboration between researchers, healthcare professionals, and industry partners to ensure rigorous study design, ethical standards, and comprehensive data analysis. By prioritizing scientific excellence and community health, NTNU aims to contribute significantly to the advancement of medical knowledge and the improvement of patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Yu-Kai Chang, Ph.D.
Study Director
Department of Physical Education and Sport Sciences, National Taiwan Normal University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials